临床表现ppt课件

上传人:494895****12427 文档编号:241354538 上传时间:2024-06-20 格式:PPT 页数:45 大小:289.79KB
返回 下载 相关 举报
临床表现ppt课件_第1页
第1页 / 共45页
临床表现ppt课件_第2页
第2页 / 共45页
临床表现ppt课件_第3页
第3页 / 共45页
点击查看更多>>
资源描述
Viral HepatitisDept.of Infectious Diseases SunYat-sen University Q.F.XIE临床表现课件1Viral HepatitisDept.of InfeIntroductionViral hepatitis are a group of diseases,Caused by A、B、C、D and E 5 hepatitis virusHepatitis A and E Transmitted by fecal-oral route,present acute and self-limited courseHepatitis B,C and D Spread parenterally easily lead to chronic hepatitis临床表现课件2IntroductionViral hepatitis arClinical characters including fatigue,intestinal symptoms tender and enlarged liver abnormal LFTs jaundice in some cases very variable in severity临床表现课件3临床表现课件3SignificanceHighly endemicWide clinical spectrumHigh fatality rate in severe casesNo specific pathogenic therapy available nowChronic hepatitis B and C very common,some may develop to cirrhosis even HCCSuccessful vaccination for HBV and HAV临床表现课件4SignificanceHighly endemic临床表现Etiology-HAVHeparnavirusAppeared in bile and feces,spreaded via fecesNo chronic carrier status observedAnti-HAV antibody to HAVAnti-HAV IgM indicative of current or recent infection appeared very early,disappear in about 3months most useful for confirm the diagnosis临床表现课件5Etiology-HAVHeparnavirus临床表现课件Anti HAV IgG current or previous infection a protective antibody,conferring immunity persist for life long time临床表现课件6临床表现课件6Etiology-HBVOrthohepadnavirus,Dane particle4 open reading frame:S,C,P,X8 genotypes A-H,B and C predominantly in ChinaStrong ability against to environment3 antigen and antibody system临床表现课件7Etiology-HBVOrthohepadnavirus,HBsAg found in serum and other body fluid not infectious itself suggesting current infection and infectivity Anti-HBs a protective antibody to HBsAg an indicator of past infection and immunity to HBV reinfection suggesting non-infectious临床表现课件8HBsAg临床表现课件8HBeAg suggesting HBV replication and high infectivity negative when pre-C mutation but with high level of replication useful for evaluation of anti-HBV therapyAnti-HBe antibody to HBeAgHBe seroconversion HBeAg(+)(-)and anti-HBe(-)(+)临床表现课件9HBeAg临床表现课件9HBcAg existing in the core of virion a marker of replication and infectivityAnti-HBc IgM a marker of acute primary HBV infectionAnti-HBc IgG appeared in almost all HBV present and past infection host body临床表现课件10HBcAg临床表现课件10HBVDNA the genome of HBV suggesting active virus replication and infectivity useful for diagnosis and evaluation of anti-HBV therapy临床表现课件11HBVDNA临床表现课件11Hepatitis B Virus临床表现课件12Hepatitis B Virus临床表现课件12Etiology-HCVRNA virus,6genotypes,mainly 1b in the countryMolecular heterogeneity driven by high mutation rate usually proceed to chronic courseAnti-HCV IgM and IgG types antibody to HCV suggesting HCV infection临床表现课件13Etiology-HCVRNA virus,6genotyHCVRNA the genome of HCV suggesting replication and infectivity of HCV useful for the diagnosis and evaluation of antivirus treatment临床表现课件14HCVRNA临床表现课件14Etiology-HDVAn incomplete RNA virusCauses hepatitis only patients with either acute(coinfection)or chronic(superinfection)hepatitis B HDVAg and anti-HDV both the markers of HDV infection HDVRNA the genome of HDV a marker of existing HDV infection suggesting virus replication and infectivity临床表现课件15Etiology-HDVAn incomplete RNA Etiology-HEVNonenveloped RNA virusAppeared in bile and feces,spreaded via fecesNo chronic carrier status observedAnti-HEV IgM and IgG both appeared in acute infection useful for the diagnosis of HEV infection临床表现课件16Etiology-HEVNonenveloped RNA vHEVRNA the genome of the virus suggesting existing of HEV infection not available for routine clinical diagnosis临床表现课件17HEVRNA临床表现课件17EpidemiologySource of infection Patients with acute or chronic viral hepatitis Carriers of hepatitis virus,particularly asymptomatic carriers临床表现课件18EpidemiologySource of infectioTransmission Hepatitis A and E transmitted by the fecal-oral route,water-borne and food-transmitted infection in epidemics临床表现课件19Transmission临床表现课件19Hepatitis B transmitted parenterally mother-to-infant play a key role in China blood,blood products and body fluid othersHepatitis C and D similar to hepatitis B intravenous drug abusers most common hepatitis C for the time being 临床表现课件20临床表现课件20Prevalence rate in China 1992Hepatitis A anti-HAV+80.90%Hepatitis B HBsAg +9.75%(2006)7.18%Hepatitis C anti-HCV+3.20%Hepatitis D anti-HDV+1.15%Hepatitis E anti-HEV+17.2%临床表现课件21Prevalence rate in China 1992HPathogenesisHepatocellular damage produced by viral replication directly only in hepatitis DOther types of viral hepatitis induced mainly by immune-mediated attack on the liver临床表现课件22PathogenesisHepatocellular damPathologyThe varying lesion could be seen in entire liver,but variable in severity and in different stages of the diseaseNo specific lesion suggesting etiologic type of hepatitis virus临床表现课件23PathologyThe varying lesion coClinical manifestationsWide clinical spectrum from asymptomatic form to fatal outcome such as liver failureSimilar clinical course in different etiological type of viral hepatitis 临床表现课件24Clinical manifestationsWide clThe clinical types viral hepatitisAcute hepatitisChronic hepatitisLiver failure(severe hepatitis)Cholestatic viral hepatitisHepatitis cirrhosisAsymptomatic virus carrier status(usually only in HBV)临床表现课件25The clinical types viral hepatIncubation period Hepatitis A 2-6w 4w Hepatitis E 2-9w 6w Hepatitis B 1-6m 3m Hepatitis C 2w-6m 6w Hepatitis D 4-20w临床表现课件26Incubation period临床表现课件26Acute hepatitis 3 phases of the icteric hepatitis Prodromal phase sudden or insidious onset,lasting 3-7d constitutional symptom:malaise,fatigue,mild fever some time,dark urine gastrointestinal symptoms:anorexia,nausea,vomiting serum ALT level rise deeply临床表现课件27Acute hepatitis临床表现课件27Jaundice phase jaundice appeared and peak level often in 2 weeks after the onset other symptoms subside after jaundice tender liver palpable serum bilirubin elevated lasting for 26 weeks临床表现课件28Jaundice phase临床表现课件28Convalescent phase symptoms and jaundice gradual resolution liver return to normal size serum ALT and bilirubin decreased 1 to 2 months neededAnicteric acute viral hepatitis more common,mild manifastation临床表现课件29Convalescent phase临床表现课件29Chronic hepatitis Seen only in hepatitis B,C and D,virus infection over 6 months Severity variable,3 subtypes:mild,typical and advanced Common manifestations:malaise,fatigue,poor appetite,nausea,distension of abdomen 临床表现课件30Chronic hepatitis临床表现课件30Jaundice seen in some casesEnlargement of liver and/or spleenSpider naevi,hepatic palms in cases with long historyAbnormal LFTs:transaminase,bilirubin A/GPrognosis different:stable,breakthrough or flare,develop to Cir or Ca临床表现课件31Jaundice seen in some cases临床表Liver failure(severe hepatitis)Bad prognosis Pathological basis:extensive necrosis of hepatic cells 4 subtypes:acute liver failure,subacute,acute-on-chronic,chronic Clinical syndrome including:jaundice deepen rapidly临床表现课件32Liver failure(severe hepatiti liver size become smaller bleeding,prolonged prothrombin time,PTA less than 40%cerebral edema,high intracranial pressure complicated infection:SBP hepatic encephalopathy toxic abdominal distension and ascites hepatic-renal syndrome 临床表现课件33 liver size become smallCholestatic viral hepatitisacute and chronic mild manifestation but deepen jaundiceHepatitis cirrhosis hepatic fibrosis compensated cirrhosis decompensated cirrhosis临床表现课件34Cholestatic viral hepatitis临床表Asymptomatic HBV carrier HBV infection more than 6 months have no symptoms and signs normal LFTs 70%-80%have no pathologic change in liver biopsy临床表现课件35临床表现课件35DiagnosisClinical DataEpidemiological evidencesLaboratory investigationsUltrasoundBiopsy临床表现课件36DiagnosisClinical Data临床表现课件36Differential diagnosisJaundice caused by other etiological agentsHepatitis caused by other etiological agents临床表现课件37Differential diagnosisJaundiceTreatmentBasic principles of management guideline for daily living,physical activity,food and drink intake of the patients supportive and symptomatic treatment 临床表现课件38TreatmentBasic principles of mHepatic function protective agentsAnti-virus therapy most important treatment for chronic hepatitis B、acute and chronic hepatitis Chepatitis B indication:HBVDNA 105copies/ml for HBeAg,临床表现课件39Hepatic function protective ag HBVDNA 104copies/ml for HBeAg+;ALT 2ULN,or biopsy G2S2 Drugs:interferon-(typical or pegylated)or,nucleotide analogues:3TC,adfovir,entecavir,Ldt Hepatitis C indication:HCVRNA+drugs:interferon-(typical or pegylated)+ribavirin临床表现课件40 HBVDNA 104copies/ml for Traditional Chinese medicineManagement for liver failure basic supportive therapy treatment of complications bleeding infection complications encephalopathy renal failure临床表现课件41 Traditional Chinese mediciHepatic transplantationManagement of asymptomatic HBV carrier medical check up periodically no any alcohol intake liver biopsy when patients age more than 40 years and HBV replication in high level临床表现课件42Hepatic transplantation临床表现课件4PreventionImprovement of sanitationBlood screening of donorsAnti-virus treatment for hepatitis B and hepatitis C临床表现课件43PreventionImprovement of sanitImmunoprophylaxis active immunization vaccines for hepatitis A and B are available around world,very successful for pre-exposure prevention passive immunization IG for hepatitis A,HBIG for hepatitis B;post-exposure临床表现课件44Immunoprophylaxis临床表现课件44 Thanks!临床表现课件45 Thanks!临床表现课件45
展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 办公文档 > 教学培训


copyright@ 2023-2025  zhuangpeitu.com 装配图网版权所有   联系电话:18123376007

备案号:ICP2024067431-1 川公网安备51140202000466号


本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知装配图网,我们立即给予删除!